Know Cancer

or
forgot password

Circulating Tumor Cells Identification in Advanced Stage Non-small Cell Lung Cancer


N/A
N/A
N/A
Open (Enrolling)
Both
Stage IIIB Non Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer

Thank you

Trial Information

Circulating Tumor Cells Identification in Advanced Stage Non-small Cell Lung Cancer


Inclusion Criteria:



- Advanced stage NSCLC (stages IIIB, and IV) with measurable or evaluable disease at
diagnosis.

- Age ≥ 18 years.

- Measurable or evaluable disease according to RECIST criteria.

- Ability to sign informed consent.

Exclusion Criteria:

- Prior cancers within 5 years, except for non-melanoma skin cancers, and in situ
cervical cancers.

- Prior chemotherapy, radiation or surgery for lung cancer.

- Inability to comply with study and/or follow-up procedures.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Identification of circulating tumor cells in locally advanced, and metastatic non-small cell lung cancer.

Outcome Description:

Circulating tumor cells will be search with the Veridex method, and a value per 7.5 f blood will be recorded.

Outcome Time Frame:

18 months

Safety Issue:

No

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

2012-A00135-38

NCT ID:

NCT01658332

Start Date:

June 2012

Completion Date:

Related Keywords:

  • Stage IIIB Non Small Cell Lung Cancer
  • Stage IV Non-Small Cell Lung Cancer
  • lung cancer
  • circulating tumor cells
  • prospective
  • monocentrique trial
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Neoplastic Cells, Circulating

Name

Location